The U.S. Food and Drug Administration said on Tuesday it has sent warning letters to four companies for selling unapproved ...

The U.S. Food and Drug Administration said on Tuesday it has sent warning letters to four companies for selling unapproved ...

经济观察网讯 中国贸易救济信息网消息，12月9日，美国国际贸易委员会（ITC）发布公告称，对特定含有替尔泊肽的产品和声称含有替尔泊肽的产品（Certain Products Containing Tirzepatide and Products ...

Patients lost an average of 20.2% of their weight with tirzepatide over 72 weeks versus 13.7% with semaglutide.

This came after Eli Lilly and Company (India) presented the justification for Cmax values at a 90% confidence interval based ...

The FDA put both peptides on its shortage list in 2022. Semaglutide is still on that list, while the FDA lifted its shortage ...

The most common adverse events reported with both treatments were mild to moderate gastrointestinal-related side effects.

It’s likely to still be there at the end of the year, but by the time the final sales figures for 2024 are tallied up, Novo ...

Researchers explore the therapeutic potential and clinical insights of GP1-RAs in the management of metabolic ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) is currently a pressing public health issue associated with ...